Synapse Open Synapse
Biology

London biotech Oyster harvests $60M for tau-targeting brain drugs

BioPharma Dive · · 2 min read

Oyster says a tweak it's made to traditional protein degrading technology can help break down tau, which has long been a focus of Alzheimer’s drug research.

Latest from BioPharma Dive